Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2011-2-2
pubmed:abstractText
Although it is accepted that metastatic colorectal cancers (mCRCs) that carry activating mutations in KRAS are unresponsive to anti-epidermal growth factor receptor (EGFR) monoclonal antibodies, a significant fraction of KRAS wild-type (wt) mCRCs are also unresponsive to anti-EGFR therapy. Genes encoding EGFR ligands amphiregulin (AREG) and epiregulin (EREG) are promising gene expression-based markers but have not been incorporated into a test to dichotomise KRAS wt mCRC patients with respect to sensitivity to anti-EGFR treatment.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-11097226, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-11531254, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-12098689, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-14993230, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-15269313, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-15625347, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-15677698, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-15677699, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-15753456, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-15863375, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-16024606, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-17363584, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-17375050, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-17664471, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-17697383, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-17974556, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-17998284, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-18202412, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-18316791, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-18621636, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-18669866, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-18794099, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-18946061, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-19001320, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-19002188, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-19188670, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-19223544, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-19240792, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-19366826, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-19603018, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-19603024, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-19738126, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-19826350, http://linkedlifedata.com/resource/pubmed/commentcorrection/21206494-19846928
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1532-1827
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
104
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
488-95
pubmed:dateRevised
2011-7-26
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer.
pubmed:affiliation
Genomic Health, Inc., 301 Penobscot Drive, Redwood City, CA, USA.
pubmed:publicationType
Journal Article